Notwithstanding the fact that chromophobe RCC (chRCC) very seldom metastasizes, mitochondrial alterations, tumor protein p53 (p53) mutations, and activation of mammalian target of rapamycin (mTOR) pathways have been described [15]. This evidence concerns the gene MTOR and chromophobe renal cell carcinoma.